William Blair Has Bearish Forecast for PBH Q3 Earnings

Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) - Research analysts at William Blair cut their Q3 2026 earnings per share (EPS) estimates for shares of Prestige Consumer Healthcare in a research report issued to clients and investors on Thursday, August 7th. William Blair analyst J. Andersen now anticipates that the company will post earnings per share of $1.19 for the quarter, down from their prior estimate of $1.25. The consensus estimate for Prestige Consumer Healthcare's current full-year earnings is $4.50 per share. William Blair also issued estimates for Prestige Consumer Healthcare's Q4 2026 earnings at $1.40 EPS and FY2027 earnings at $4.82 EPS.

Several other brokerages also recently commented on PBH. Wall Street Zen downgraded Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Finally, Canaccord Genuity Group reduced their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Performance

NYSE PBH traded down $1.83 during trading on Monday, hitting $64.60. The company's stock had a trading volume of 513,689 shares, compared to its average volume of 383,771. The company has a quick ratio of 2.99, a current ratio of 4.38 and a debt-to-equity ratio of 0.55. The firm has a 50 day moving average price of $78.07 and a 200 day moving average price of $81.78. The firm has a market cap of $3.18 billion, a P/E ratio of 15.16, a price-to-earnings-growth ratio of 2.06 and a beta of 0.43. Prestige Consumer Healthcare has a 52 week low of $62.95 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%. The company had revenue of $249.53 million during the quarter, compared to analyst estimates of $260.71 million. During the same quarter last year, the firm posted $0.90 earnings per share. The firm's revenue for the quarter was down 6.6% compared to the same quarter last year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. Diversify Wealth Management LLC increased its stake in shares of Prestige Consumer Healthcare by 23.7% in the 2nd quarter. Diversify Wealth Management LLC now owns 15,995 shares of the company's stock valued at $1,277,000 after purchasing an additional 3,066 shares during the last quarter. Diversify Advisory Services LLC boosted its holdings in shares of Prestige Consumer Healthcare by 27.9% during the 2nd quarter. Diversify Advisory Services LLC now owns 5,581 shares of the company's stock valued at $446,000 after acquiring an additional 1,217 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Prestige Consumer Healthcare by 12.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 553,407 shares of the company's stock valued at $44,190,000 after acquiring an additional 63,168 shares in the last quarter. Squarepoint Ops LLC boosted its holdings in shares of Prestige Consumer Healthcare by 6.3% during the 2nd quarter. Squarepoint Ops LLC now owns 72,555 shares of the company's stock valued at $5,794,000 after acquiring an additional 4,308 shares in the last quarter. Finally, Cerity Partners LLC lifted its holdings in Prestige Consumer Healthcare by 5.9% during the 2nd quarter. Cerity Partners LLC now owns 3,884 shares of the company's stock worth $310,000 after buying an additional 218 shares during the period. Institutional investors own 99.95% of the company's stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.